US equities |
NVDA $186.64 ▲+2.78% MU $690.00 ▲+5.12% AMD $449.04 ▲+11.04% SPCX $134.27 ▲+8.62% AAPL $342.37 ▼-0.52% SNDK $835.06 ▲+3.55% MSFT $530.61 ▼-0.99% TSLA $358.22 ▲+4.23%
FinancialContent

Articles published by DataMEDS AI, Inc.

News headline image
DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers DVLT MEDS
News headline image
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI Provides Update on Corexa Health's Pharmacy Division
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers DVLT MEDS SCLX
News headline image
DataMeds Regains Compliance With NASDAQ Listing Standards
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers DVLT MEDS
News headline image
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers DVLT MEDS
News headline image
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS AI Unveils New Corporate Website
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers AGPU MEDS
News headline image
Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers DVLT MEDS
News headline image
CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers DVLT MEDS
News headline image
DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS
News headline image
DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers DVLT MEDS
News headline image
DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers DVLT MEDS
News headline image
DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
From DataMEDS AI, Inc.
Via ACCESS Newswire
Tickers MEDS WGRX